We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02760797
Recruitment Status : Completed
First Posted : May 4, 2016
Last Update Posted : May 22, 2018
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche